Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2017 (2017), Article ID 4385161, 7 pages
https://doi.org/10.1155/2017/4385161
Clinical Study

Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial

1Department of Gastroenterology, Nagano Red Cross Hospital, Nagano, Japan
2Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan
3Digestive Disease Center, Showa Inan General Hospital, Komagane, Japan
4Department of Gastroenterology, Aizawa Hospital, Matsumoto, Japan

Correspondence should be addressed to Masafumi Maruyama; pj.ro.crj.dem-onagan@amayuram.m

Received 27 October 2016; Accepted 18 January 2017; Published 28 February 2017

Academic Editor: Michael Beyak

Copyright © 2017 Masafumi Maruyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Masafumi Maruyama, Naoki Tanaka, Daisuke Kubota, et al., “Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial,” Canadian Journal of Gastroenterology and Hepatology, vol. 2017, Article ID 4385161, 7 pages, 2017. doi:10.1155/2017/4385161